This Article Full Text Full Text (PDF) An erratum has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lipkin, A. C. Articles by Lenssen, P. Search for Related Content PubMed PubMed Citation Articles by Lipkin, A. C. Articles by Lenssen, P. Social Bookmarking                         What's this?

Hypervitaminosis A in Pediatric Hematopoietic Stem Cell Patients Requiring Renal Replacement Therapy

From Seattle Childrens Hospital and Regional Medical Center, Seattle, Washington.

Correspondence: Address correspondence to: Anne C. Lipkin, Seattle Childrens Hospital and Regional Medical Center, Clinical Nutrition, W-3726 Seattle, WA 98105; e-mail: ann.lipkin{at}seattlechildrens.org; alipki{at}u.washington.edu.

Background: Chronic renal failure patients have been known to develop vitamin A toxicity, but a descriptive study of hypervitaminosis A in patients with acute renal failure (ARF) has not yet been published. The authors observed hypervitaminosis A in pediatric hematopoietic stem cell transplant (HSCT) patients. Methods: All HSCT patients admitted between January 2001 and May 2006 who experienced ARF, received renal replacement therapy (RRT), and had a vitamin A level drawn were included in this retrospective, descriptive study. Molar ratios of vitamin A and retinol-binding protein (RBP) were calculated to more accurately assess vitamin A status. Nineteen patients met the criteria for this study. Results: At initial testing (generally between days 6 and 10 after initiation of RRT), 17 of the 19 patients had abnormally elevated vitamin A levels for their age. Molar ratios of vitamin A to RBP were elevated in 6 patients at initial testing. Prescribed vitamin A intake information (parenteral and enteral) was available for most patients; all but 3 had an average daily intake greater than 2000 IU/kg over the 30 days prior to RRT initiation. Many patients had symptoms possibly related to vitamin A toxicity, although interpretation of hair, skin, and liver abnormalities are difficult to ascertain in HSCT patients. Seven patients had other findings that may have been associated with vitamin A toxicity. Conclusion: Children undergoing HSCT who receive nutrition support (predominantly parenteral nutrition), experience ARF, and require RRT are at risk for hypervitaminosis A and toxicity.

Key Words: hypervitaminosis A • vitamin A • bone marrow transplantation • acute kidney failure • renal insufficiency • kidney diseases • renal dialysis • renal replacement therapy • hemodiafiltration • dialysis • renal dialysis • critical care • intensive care • pediatric intensive care units

Nutrition in Clinical Practice, Vol. 23, No. 6, 621-629 (2008)
DOI: 10.1177/0884533608327082


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Doley Nutrition Management of Pressure Ulcers Nutr Clin Pract, February 1, 2010; 25(1): 50 - 60. [Abstract] [Full Text] [PDF]

				E. Fiaccadori, G. Regolisti, and A. Cabassi Specific nutritional problems in acute kidney injury, treated with non-dialysis and dialytic modalities NDT Plus, February 1, 2010; 3(1): 1 - 7. [Abstract] [Full Text] [PDF]